Macular Disease Foundation Australia logo

    Research news

    Research News

    MDFA awarded a total funding pool of more than $1 million in May 2021 to eight exciting researchers, bringing our total investment in research to $5.1m since 2011.

    Read more

    Most recent

    Investigating macular oedema

    This exciting research project, being funded by Macular Disease Foundation Australia’s Research Grants Program, is looking at the potential to use existing drugs to treat macular oedema.

    Understanding AMD at a cellular level

    Dr Zhang has been awarded $45,000 under the new Grant Family Fund, set up to provide funding for early career researchers, embarking on ‘blue sky’ projects with the potential to shift our thinking on macular disease.

    Macular Disease Foundation Australia awards $1 million to eight exciting research projects

    Macular Disease Foundation Australia (MDFA) has awarded more than $1 million in research funding to eight promising projects, in a ceremony marking 10 years of significant advances in the search for a cure to Australia’s leading cause of blindness.

    New gene therapy for AMD

    MDFA funded researcher, Dr Yvette Wooff is investigating cell particles called extracellular vesicles (EV), which could help develop novel gene therapies for dry AMD.

    10 years of MDFA Research Grants

    Celebrating the 10th anniversary of MDFA’s Research Grants Program, this free publication introduces you to all the talented researchers your donations have funded since 2011.

    Macular research clinical trials

    The Centre for Eye Research Australia (CERA) teamed up with MDFA’s webinar series for the latest research updates on AMD, including how you can take part in vision research.

    Grant Family Fund bequest: Lasting legacy to ‘best mates’

    Faye Grant included MDFA in her Will. Her bequest is now funding vital, innovative research into macular disease through the Grant Family Fund.

    Million-dollar funding for macular disease research on World Sight Day

    MDFA will award $1 million in its latest round of research funding. It also announced a new stream of ‘blue sky’ grant funding.

    Scientists test potential drug developed in Australia

    A new chemical compound could become a future tool against retinal vascular disease. The finding is the result of a pre-clinical study, led by UNSW researchers.